EL PAÍS English9h
Keytruda: The drug that makes as much money as Zara and has sparked debate over patent lifespans
MSD’s monoclonal antibody, indicated for 15 types of cancer, smashed industry records with sales of $27.3 billion in 2024, ...
Fierce Pharma11h
Amid uncertainty in the US, Boehringer Ingelheim projects 'slight' revenue increase for '25
Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer ...